Wuputra K, Hsiao P, Chang W, Wu P, Chen L, Huang J, et al. FOXM1-CD44 Signaling Is Critical for the Acquisition of Regorafenib Resistance in Human Liver Cancer Cells. Int J Mol Sci. 2022;23: pubmed publisher

Young M, Chen Y, Wang S, Chang H, Yang W, Lee C, et al. Estradiol-mediated inhibition of Sp1 decreases miR-3194-5p expression to enhance CD44 expression during lung cancer progression. J Biomed Sci. 2022;29:3 pubmed publisher

Canella A, Cordero Nieves H, Sborov D, Cascione L, Radomska H, Smith E, et al. HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide. Oncotarget. 2015;6:31134-50 pubmed publisher

Godar S, Ince T, Bell G, Feldser D, Donaher J, Bergh J, et al. Growth-inhibitory and tumor- suppressive functions of p53 depend on its repression of CD44 expression. Cell. 2008;134:62-73 pubmed publisher